Event Listings
 
4th Oncolytic Virotherapy Summit 2018

As many oncolytic viruses progress through the clinical pipelines, drug developers need to ensure that their therapies are safe, efficacious and commercially viable. Make sure you stay ahead of the game and join Oncolytic Virotherapy Summit, where you will have an opportunity to pick the brains of 100+ senior industry peers and tackle your challenges in discovery, clinical development, manufacturing and regulations of oncolytic virotherapy.

This year we will be incorporating commercial insights from companies such as Merck, Virogen, Sagetis, Lokon Pharma, Replimmune, Western Oncolytics, DNAtrix and many more, which will allow you to learn from their case studies and improve your development strategies. Participate in the interactive roundtable and workshops to build strategies that maximise success in the clinic and commercially.

Sounds interesting? Find out more – get free event brochure here: http://bit.ly/2vsAIRC

URLs:
Brochure: https://go.evvnt.com/260431-0?pid=4870
Website: https://go.evvnt.com/260431-2?pid=4870

Price
Conference + 2 Workshops (Drug Developers): GBP 3797.0
Conference + 1 Workshop (Drug Developers): GBP 3298.0
Conference Only (Drug Developers): GBP 2799.0
Workshops (Each) (Drug Developers): GBP 599.0
Conference + 2 Workshops (Academic): GBP 2397.0
Conference + 1 Workshop (Academic): GBP 1998.0
Conference Only (Academic): GBP 1599.0
Workshops (Each) (Academic): GBP 499.0
Conference + 2 Workshops (Vendor & Solution Providers): GBP 4297.0
Conference + 1 Workshop (Vendor & Solution Providers): GBP 3698.0

Speakers: Grant McFadden, Center Director & Professor, Biodesign Center for Immunotherapy, ASU, Masataka Suzuki, Assistant Professor, Baylor College of Medicine, Brad Nelson, Director, Deeley Research Centre BC Cancer Agency, Frank Tufaro, CEO, DNAtrix, Antonio Chiocca, Professor, Harvard Medical School, Faris Farassati, Associate Professor, University of Kansas Medical School, Angelica Loskog, CEO, Lokon Pharma, Rachel Altura, Senior Medical Director, Merck & Co., Christophe Queva, Chief Scientific Officer, Oncorus, Steven Potts, CEO, OncoMyx, Robert Coffin, CEO, Replimmune, Anna Cascante, Head of R&D, Sagetis Biotech, Magnus Jaderberg, CMO, Targovax, Min Liang, CSO, TOT biopharma, José Manuel Otero, Vice President, CMC & Manufacturing, Turnstone Biologics, Daniel Katzman, Chief Executive Officer, Unleash Immuno Oncolytics, Stephen Thorne, Chief Scientific Officer, Western Oncolytics, William Jia, Chief Scientific Officer, Virogen


Event Date: 4 December 2018 - 6 December 2018 Contact Person: Margo Gantner
Venue: Hilton Boston Back Bay, 40 Dalton Street, Boston, MA 02115 Email:
Country: United States Tel: +1 6174554188

Registration Website: http://go.evvnt.com/260431-3?pid=4870

Submitted by Love Evvnt, Evvnt on Tuesday, 4 December 2018 at 8:00 AM
Category: Health Care & Medical
 
Related News

Hypoparathyroidism Treatment Market Market Report 2016 and Future Opportunity Assessment 2027
Tuesday, 26 Mar 2019

Antidiuretics Market Research Key Players, Industry Overview and Forecasts to 2024
Tuesday, 26 Mar 2019

Vascular Trauma Management Market Market Competitive Landscape Analysis with Forecast by 2025
Tuesday, 26 Mar 2019

Diabetic Retinopathy Market Overview and Regional Outlook Study 2017 - 2025
Tuesday, 26 Mar 2019

Onchocerciasis Treatment Market Market Growth Opportunities & Technology Developments by 2025
Tuesday, 26 Mar 2019

Related Events

Diagnostic Imaging Update on Kauai
Monday, 25 Mar 2019

8th Drug Formulation and Bioavailability
Monday, 25 Mar 2019

Slow- and Controlled-Release and Stabilized Fertilizers (SCRSFs)
Monday, 25 Mar 2019

3rd Product Complaints Forum
Monday, 25 Mar 2019

14 International Conference on Alzheimer's and Parkinson's Diseases AD/PD™
Tuesday, 26 Mar 2019

Upcoming Events

Palo Alto Networks: CCISDA Spring Conference 2019
Sunday, 24 Mar 2019

Diagnostic Imaging Update on Kauai
Monday, 25 Mar 2019

Gulf Safety Forum 2019
Monday, 25 Mar 2019

2nd Pharmacovigilance Audit and Inspection Conference
Monday, 25 Mar 2019

8th Drug Formulation and Bioavailability
Monday, 25 Mar 2019

 
Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2019
Today is Tuesday, 26 March 2019

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Business
Consumer Technology
Economy
Education
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
Legal/Law
News & Media
Religion
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!


Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.


  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.


    Resources
  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Latest Press Releases
  • Electronics at the nanoscale: challenges and opportunities for making metal nanowires
  • Hypoparathyroidism Treatment Market Market Report 2016 and Future Opportunity Assessment 2027
  • Antidiuretics Market Research Key Players, Industry Overview and Forecasts to 2024
  • Vascular Trauma Management Market Market Competitive Landscape Analysis with Forecast by 2025
  • Diabetic Retinopathy Market Overview and Regional Outlook Study 2017 - 2025

  • Latest Jobs
    Sorry, there are currently no entries posted here.